Showing 1331-1340 of 1753 results for "".
Trends and Trendsetters of 2014
https://practicaldermatology.com/topics/general-topics/trends-and-trendsetters-of-2014/21259/Highlights from the year, including fresh ideas from industry and innovations from physicians.Nonclinical Staff: Sing the Praises of Your Unsung Heroes
https://practicaldermatology.com/topics/practice-management/nonclinical-staff-sing-the-praises-of-your-unsung/21284/The front-office team plays a critical role in the success of your practice.The Molecular Era in Melanoma Treatment
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-molecular-era-in-melanoma-treatment/21296/The Most Important Element of Your Financial Plan, Part II
https://practicaldermatology.com/topics/practice-management/the-most-important-element-of-your-financial-plan-part-ii/21313/Why flexibility is crucial to meeting long-term goals.Strategic Situations
https://practicaldermatology.com/topics/practice-management/strategic-situations/21303/Should you consider adding a patient care coordinator?Creating Loyal Patients
https://practicaldermatology.com/topics/practice-management/creating-loyal-patients/21360/A look at current research and best practices.Converting Telephone Inquiries into New Patients Through Mystery Shopping
https://practicaldermatology.com/topics/practice-management/converting-telephone-inquiries-into-new-patients-through-mystery-shopping/21371/Tips to help practices convert calls into appointments.The Melanoma Pipeline
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-melanoma-pipeline/21400/A closer look at the latest data for two investigational agents that have made headlines.Google Authorship Can Boost a Dermatologist's Online Profile
https://practicaldermatology.com/topics/practice-management/google-authorship-can-boost-a-dermatologists-online-profile/21437/Weighing the Prospects of Biosimilars
https://practicaldermatology.com/columns/clinical-focus-1/weighing-the-prospects-of-biosimilars/21477/If they are found to be comparable to the “originators,” biosimilar agents may offer patients significant therapeutic benefits as well as cost efficiency.